Structure−Function Relationships of Inhibition of Human Cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 Flavonoid Derivatives
- 5 November 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 23 (12), 1921-1935
- https://doi.org/10.1021/tx100286d
Abstract
Structure−function relationships for the inhibition of human cytochrome P450s (P450s) 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives were studied. Thirty-two of the 33 flavonoids tested produced reverse type I binding spectra with P450 1B1, and the potencies of binding were correlated with the abilities to inhibit 7-ethoxyresorufin O-deethylation activity. The presence of a hydroxyl group in flavones, for example, 3-, 5-, and 7-monohydroxy- and 5,7-dihydroxyflavone, decreased the 50% inhibition concentration (IC50) of P450 1B1 from 0.6 μM to 0.09, 0.21, 0.25, and 0.27 μM, respectively, and 3,5,7-trihydroxyflavone (galangin) was the most potent, with an IC50 of 0.003 μM. The introduction of a 4′-methoxy- or 3′,4′-dimethoxy group into 5,7-dihydroxyflavone yielded other active inhibitors of P450 1B1 with IC50 values of 0.014 and 0.019 μM, respectively. The above hydroxyl and/or methoxy groups in flavone molecules also increased the inhibition activity with P450 1A1 but not always toward P450 1A2, where 3-, 5-, or 7-hydroxyflavone and 4′-methoxy-5,7-dihydroxyflavone were less inhibitory than flavone itself. P450 2C9 was more inhibited by 7-hydroxy-, 5,7-dihydroxy-, and 3,5,7-trihydroxyflavones than by flavone but was weakly inhibited by 3- and 5-hydroxyflavone. Flavone and several other flavonoids produced type I binding spectra with P450 3A4, but such binding was not always related to the inhibitiory activities toward P450 3A4. These results indicate that there are different mechanisms of inhibition for P450s 1A1, 1A2, 1B1, 2C9, and 3A4 by various flavonoid derivatives and that the number and position of hydroxyl and/or methoxy groups highly influence the inhibitory actions of flavonoids toward these enzymes. Molecular docking studies suggest that there are different mechanisms involved in the interaction of various flavonoids with the active site of P450s, thus causing differences in inhibition of these P450 catalytic activities by flavonoids.Keywords
This publication has 47 references indexed in Scilit:
- Theoretical Characterization of Substrate Access/Exit Channels in the Human Cytochrome P450 3A4 Enzyme: Involvement of Phenylalanine Residues in the Gating MechanismThe Journal of Physical Chemistry B, 2009
- Mechanism of CYP2C9 Inhibition by Flavones and FlavonolsDrug Metabolism and Disposition, 2008
- Cancer phytotherapeutics: role for flavonoids at the cellular levelPhytotherapy Research, 2008
- Bioavailable Flavonoids: Cytochrome P450-Mediated Metabolism of MethoxyflavonesDrug Metabolism and Disposition, 2007
- Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?Seminars in Cancer Biology, 2007
- Cancer chemopreventive properties of orally bioavailable flavonoids—Methylated versus unmethylated flavonesBiochemical Pharmacology, 2006
- Structural basis for ligand promiscuity in cytochrome P450 3A4Proceedings of the National Academy of Sciences, 2006
- Inhibition of Human Cytochrome P450 1A1-, 1A2-, and 1B1-Mediated Activation of Procarcinogens to Genotoxic Metabolites by Polycyclic Aromatic HydrocarbonsChemical Research in Toxicology, 2006
- Inhibition of Extrahepatic Human Cytochromes P450 1A1 and 1B1 by Metabolism of Isoflavones Found in Trifolium pratense (Red Clover)Journal of Agricultural and Food Chemistry, 2004
- Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4Biochemistry, 1997